agilon health, inc.
AGL
$96.58
$3.854.15%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.25% | -7.28% | 3.14% | -1.05% | -5.92% |
| Total Other Revenue | -38.09% | -34.17% | -22.73% | -10.85% | -7.42% |
| Total Revenue | 7.15% | -7.33% | 3.09% | -1.08% | -5.92% |
| Cost of Revenue | -4.13% | -8.54% | 6.37% | -0.80% | -0.22% |
| Gross Profit | 304.36% | 28.18% | -137.01% | -5.42% | -262.94% |
| SG&A Expenses | 43.99% | -26.46% | -1.92% | -15.51% | -18.30% |
| Depreciation & Amortization | -6.22% | -1.29% | 7.31% | 19.49% | 23.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.35% | -9.27% | 6.07% | -1.29% | -0.94% |
| Operating Income | 116.74% | 146.84% | -49.43% | 3.69% | -172.88% |
| Income Before Tax | 116.85% | 1,869.74% | -79.18% | 5.54% | -244.88% |
| Income Tax Expenses | -704.84% | -85.71% | -24.64% | 43.90% | -85.13% |
| Earnings from Continuing Operations | 117.20% | 1,684.53% | -77.47% | 5.35% | -240.39% |
| Earnings from Discontinued Operations | -- | 35.71% | -100.00% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 117.20% | 303.86% | -78.54% | 6.30% | -240.17% |
| EBIT | 116.74% | 146.84% | -49.43% | 3.69% | -172.88% |
| EBITDA | 124.19% | 214.88% | -55.53% | 4.84% | -196.94% |
| EPS Basic | 117.05% | 301.87% | -77.44% | 6.95% | -238.06% |
| Normalized Basic EPS | 123.98% | 3,171.72% | -47.38% | 8.53% | -252.09% |
| EPS Diluted | 116.48% | 300.97% | -77.44% | 6.95% | -238.32% |
| Normalized Diluted EPS | 123.28% | 3,160.18% | -47.38% | 8.53% | -252.09% |
| Average Basic Shares Outstanding | 0.92% | 0.50% | 0.62% | 0.70% | 0.62% |
| Average Diluted Shares Outstanding | 3.99% | 0.88% | 0.62% | 0.70% | 0.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |